Adverse drug events during AKI and its recovery.
暂无分享,去创建一个
A. McCoy | E. Siew | J. Peterson | T. Ikizler | M. Matheny | J. Lewis | N. Peterson | I. Danciu | A. Shintani | Zachary L. Cox | Erin Neal | A. Bian | G. Bhave | Z. Cox | E. Neal | Josh F. Peterson | Zachary L. Cox
[1] Julie A. Wright,et al. Focus on health information technology, electronic health records and their financial impact: A framework for evaluating the appropriateness of clinical decision support alerts and responses , 2012, J. Am. Medical Informatics Assoc..
[2] Sushrut S Waikar,et al. Outcome of critically ill patients with acute kidney injury using the Acute Kidney Injury Network criteria* , 2011, Critical care medicine.
[3] C. Ronco,et al. Computerized decision support systems: improving patient safety in nephrology , 2011, Nature Reviews Nephrology.
[4] K. Ensrud,et al. The magnitude of acute serum creatinine increase after cardiac surgery and the risk of chronic kidney disease, progression of kidney disease, and death. , 2011, Archives of internal medicine.
[5] A. M. Reis,et al. Adverse drug events in an intensive care unit of a university hospital , 2011, European Journal of Clinical Pharmacology.
[6] Allison B McCoy,et al. A computerized provider order entry intervention for medication safety during acute kidney injury: a quality improvement report. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[7] J. Rothschild,et al. Adverse drug events in intensive care units: Risk factors, impact, and the role of team care , 2010, Critical care medicine.
[8] Michael L. Bentley,et al. Drug-induced acute kidney injury in the critically ill adult: Recognition and prevention strategies , 2010, Critical care medicine.
[9] Catherine Yoon,et al. Occurrence of adverse, often preventable, events in community hospitals involving nephrotoxic drugs or those excreted by the kidney. , 2009, Kidney international.
[10] D. Levine,et al. Therapeutic Monitoring of Vancomycin in Adults , 2009, Pharmacotherapy.
[11] Anita Zelenika,et al. Inappropriate drug dosage adjustments in patients with renal impairment. , 2009, Journal of nephrology.
[12] Eric Zapletal,et al. Research Paper: Effect of Alerts for Drug Dosage Adjustment in Inpatients with Renal Insufficiency , 2009, J. Am. Medical Informatics Assoc..
[13] PharmD Lynn L. Estes. Therapeutic Monitoring of Vancomycin in Adults , 2009 .
[14] J. Peterson,et al. Improving aminoglycoside dosing through computerized clinical decision support and pharmacy therapeutic monitoring systems. , 2008, AMIA ... Annual Symposium proceedings. AMIA Symposium.
[15] Catherine L. Liang,et al. Classifying and Predicting Errors of Inpatient Medication Reconciliation , 2008, Journal of General Internal Medicine.
[16] S. Sheen,et al. Overdose Rate of Drugs Requiring Renal Dose Adjustment: Data Analysis of 4 Years Prescriptions at a Tertiary Teaching Hospital , 2008, Journal of General Internal Medicine.
[17] John A Kellum,et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury , 2007, Critical care.
[18] Kirsten Colpaert,et al. Impact of computerized physician order entry on medication prescription errors in the intensive care unit: a controlled cross-sectional trial , 2006, Critical care.
[19] Randolph A. Miller,et al. The anatomy of decision support during inpatient care provider order entry (CPOE): Empirical observations from a decade of CPOE experience at Vanderbilt , 2005, J. Biomed. Informatics.
[20] Joseph V Bonventre,et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. , 2005, Journal of the American Society of Nephrology : JASN.
[21] R. Bellomo,et al. Acute renal failure in critically ill patients: a multinational, multicenter study. , 2005, JAMA.
[22] D. Bates,et al. The Critical Care Safety Study: The incidence and nature of adverse events and serious medical errors in intensive care* , 2005, Critical care medicine.
[23] Matthew H Samore,et al. Risk Factors for Adverse Drug Events: A 10-Year Analysis , 2005, The Annals of pharmacotherapy.
[24] John F Hurdle,et al. High rates of adverse drug events in a highly computerized hospital. , 2005, Archives of internal medicine.
[25] Jonathan Himmelfarb,et al. Spectrum of acute renal failure in the intensive care unit: the PICARD experience. , 2004, Kidney international.
[26] D. Bates,et al. Adverse drug events and medication errors: detection and classification methods , 2004, Quality and Safety in Health Care.
[27] L. Bachmann,et al. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. , 2004, Journal of the American Society of Nephrology : JASN.
[28] P. Barach,et al. Clarifying Adverse Drug Events: A Clinician's Guide to Terminology, Documentation, and Reporting , 2004, Annals of Internal Medicine.
[29] S. Schroeder,et al. How Many Hours Is Enough? An Old Profession Meets a New Generation , 2004, Annals of Internal Medicine.
[30] T. Brennan,et al. Incidence of adverse events and negligence in hospitalized patients: results of the Harvard Medical Practice Study I* , 2004, Quality and Safety in Health Care.
[31] P. Ravaud,et al. Medication misuse in hospitalized patients with renal impairment. , 2003, International journal for quality in health care : journal of the International Society for Quality in Health Care.
[32] F. Luft,et al. Long-term outcomes in acute renal failure patients treated with continuous renal replacement therapies. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[33] S. Hou,et al. Hospital-acquired renal insufficiency. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[34] D. Bates,et al. Guided medication dosing for inpatients with renal insufficiency. , 2001, JAMA.
[35] D. Bates,et al. Patient risk factors for adverse drug events in hospitalized patients. ADE Prevention Study Group. , 1999, Archives of internal medicine.
[36] Jonathan M. Teich,et al. Research Paper: Identifying Adverse Drug Events: Development of a Computer-based Monitor and Comparison with Chart Review and Stimulated Voluntary Report , 1998, J. Am. Medical Informatics Assoc..
[37] D. Bates,et al. Preventable adverse drug events in hospitalized patients: a comparative study of intensive care and general care units. , 1997, Critical care medicine.
[38] S. Schneeweiss,et al. Adverse drug events in hospitalized patients. , 1997, JAMA.
[39] D. Classen,et al. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. , 1997, JAMA.
[40] D S Stein,et al. Factors related to errors in medication prescribing. , 1997, JAMA.
[41] D. Bates,et al. The Costs of Adverse Drug Events in Hospitalized Patients , 1997 .
[42] D. Nicolau,et al. Implementation of a once-daily aminoglycoside program in a large community-teaching hospital. , 1995, Hospital pharmacy.
[43] N. Laird,et al. Incidence of Adverse Drug Events and Potential Adverse Drug Events: Implications for Prevention , 1995 .
[44] C. Safran,et al. Effect of computer-based alerts on the treatment and outcomes of hospitalized patients. , 1994, Archives of internal medicine.
[45] T. Brennan,et al. Incidence of adverse events and negligence in hospitalized patients. Results of the Harvard Medical Practice Study I. , 1991 .
[46] T. Brennan,et al. The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II. , 1991, The New England journal of medicine.
[47] H Pohl,et al. Medication prescribing errors in a teaching hospital. , 1990, JAMA.
[48] W. Bennett. Drug Prescribing in Renal Failure , 1979, Drugs.
[49] Allison B McCoy,et al. Real-time pharmacy surveillance and clinical decision support to reduce adverse drug events in acute kidney injury , 2012, Applied Clinical Informatics.
[50] R. Bellomo,et al. Kidney attack. , 2012, JAMA.
[51] D. Levine,et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. , 2009, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[52] S D Small,et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. , 1995, JAMA.
[53] John E. Bennett,et al. Principles and practice of infectious diseases. Vols 1 and 2. , 1979 .
[54] J. McCulloch,et al. CHAPTER 7 – Implications for Prevention , 1972 .
[55] E. Alpen,et al. A clinical appraisal of the plasma concentration and endogenous clearance of creatinine. , 1962, The American journal of medicine.
[56] R. Bellomo,et al. Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group , 2004, Critical care.